Respiratory physiotherapy in COVID-19: a case report
Mayron Faria Oliveira, Carlos Alberto Lopes, Miguel Koite Rodrigues
Abstract
Background: the clinical aspect of COVID-19 ranges to pneumonia to critically ill cases; however, there is a lack of studies reporting respiratory physiotherapy treatment in hospitalized COVID-19 patients. Aim: we aimed to analyze the acute respiratory physiotherapy treatment in a patient with COVID-19. Methods: A symptomatic (fever 38.0º; dry-cough; dyspnea) young patient (30 years of age) with COVID-19 received oxygen therapy and respiratory physiotherapy during hospitalization. Pulmonary function was analyzed by computed tomography (CT) and by electrical impedance tomography (EIT). Results: CT demonstrated ground-glass opacity in the right lung and EIT demonstrated an improvement in pulmonary ventilation with a reduction in the pulmonary collapse after respiratory physiotherapy; self-report symptoms (dyspnea and shortness of breath) and the oxygen therapy were reduced after respiratory physiotherapy. Conclusion: we concluded that respiratory physiotherapy, even in non-critical ill patients, could lead a better pulmonary recovery and prevent worsening the scenario in COVID-19 patients.
Keywords
Referências
1. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177-9. http:// dx.doi.org/10.1056/NEJMc2001737. PMid:32074444.
2. Simonelli C, Paneroni M, Fokom AG, Saleri M, Speltoni I, Favero I, et al. How the COVID-19 infection tsunami revolutionized the work of respiratory physiotherapists: an experience from Northern Italy. Monaldi Arch Chest Dis. 2020;90(2). http://dx.doi.org/10.4081/monaldi.2020.1085. PMid:32431134.
3. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. http://dx.doi.org/10.1016/S2213- 2600(20)30079-5. PMid:32105632.
4. Bachmann MC, Morais C, Bugedo G, Bruhn A, Morales A, Borges JB, et al. Electrical impedance tomography in acute respiratory distress syndrome. Crit Care. 2018;22(1):263. http://dx.doi.org/10.1186/s13054-018- 2195-6. PMid:30360753.
5. HuangC,WangY, LiX,RenL,ZhaoJ,HuY, et al.Clinicalfeatures of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. http://dx.doi. org/10.1016/S0140-6736(20)30183-5. PMid:31986264.
6. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. http://dx.doi. org/10.1136/bmj.m606. PMid:32075786.
7. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. http://dx.doi.org/10.1016/S2213- 2600(20)30076-X. PMid:32085846.
8. Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747-55. http://dx.doi.org/10.1056/ NEJMsa1410639. PMid:25693014.
9. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. http://dx.doi.org/10.1016/j.ijantimicag.2020.105924. PMid:32081636.
10. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. http://dx.doi.org/10.1056/ NEJMoa2001017. PMid:31978945.
Submetido em:
19/11/2020
Aceito em:
10/02/2020
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email